Peter Fedichev

I am a scientist and entrepreneur with over 20 years of experience in academic research and the biotech industry. Currently, I serve as the CEO of Gero.ai, a cutting-edge biotechnology company focused on using AI to understand and combat aging and chronic diseases. We have developed proprietary physics-based machine learning models, known as Large Health Models (LHMs), to analyze human health data and predict health outcomes. These models distinguish the effects of aging from those of diseases, enabling more precise drug discovery and development. Our goal is to create therapies that not only treat age-related diseases but also potentially extend human healthspan and lifespan.

My scientific background lies at the intersection of physics and biology, with specific expertise in condensed matter physics, biophysics, and bioinformatics. I have conducted research at the Kurchatov Institute, University of Amsterdam, FOM institute AMOLF (NL), and the University of Innsbruck (Austria). I hold an M.S. in theoretical physics from the Moscow Institute of Physics and Technology and a Ph.D. from the University of Amsterdam. I have authored more than 80 publications with over 6000 citations (h-index of 37). My work has provided key contributions to the theoretical understanding of the aging process, the rate of aging, and the limits of lifespan and age reversion.

I am passionate about the joy of discovery, the power of physics to uncover the laws of nature, and the challenge of aging research. My dream is to beat aging and experience life in space.